Felicium

Felicium

PRE-SALE ENDED
4,310 Views
Felicium removes the difficulty to use blockchain technology in everyday lives. Through autonomous Smart Agreements, traditional agreements are placed and fulfilled on the blockchain. Felicium facilitates the creation of Smart Agreements with a zero-friction experience and aims at making blockchain technology accessible to the masses.
5.8
TOTAL SCORE
7.7
ICO PROFILE

(weight: 45%)

10
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Pre-sale Time: 16 June 2020 - 14 Sept 2020
Whitelist/KYC: Whitelist + KYC
Country: The Netherlands
Token info
Ticker: FEL
Platform: Ethereum
Token Type: ERC-20
Available for sale: 150,000,000 FEL (30%)
Total supply: 500,000,000 FEL
Financial
Pre-sale Price : 1 FEL = 0.05 EUR
ICO Price: 1 FEL = 0.2 EUR
Accepting: ETH
Soft cap: 500,000 EUR
Hard cap: 25,000,000 EUR
Q4 2018
Inception of Felicium
Q1 2019
Investigated and compared various Smart Contract providers.
Q2 2019
Successfully constructed a Smart Agreement (proof of concept).<br /> Successfully constructed backend API for the Felicium Platform (proof of concept).
Q3 2019
Worked out technical and infrastructural designs to allow unlimited scaling for the Felicium Platform.<br /> Finished preliminary designs for the mobile App.<br /> Finished Whitepaper 1.0
Q1 2020
Finalized website to offer Token Sale functionality.<br />
Q2 2020
Deployed Felicium on the Ethereum blockchain.<br /> Launch of the Token Sale.<br />
Q3 2020
Deliver first milestone; creation of Smart Agreements through the Felicium Platform’s API.<br />
Q4 2020
Complete the entire UX design of website and app.<br /> Deliver second milestone; offer zerofriction registration and creation of Smart Agreements through the website.<br /> Upgrade API to offer more Smart Agreement clauses.
Q1 2021
Android, iOS and desktop app wallets and agreement integration ready.<br /> Start of beta testing of App and API.<br />
Q2 2021
Start of business partner integration and testing.<br /> Purchasing of tokens through the website and app.
Q3 2021
Delivery of first set of SDKs to seamlessly integrate Felicium’s API.<br />
Q4 2021
Official launch of the Felicium Platform.<br /> Start of customer engagement through campaigning.
Q1 2022
Construction of showcase projects, examples and continuing to extend Smart Agreement clauses.
Q2 2022
Full focus on expanding the platform.
Screenshots taken on 26 Jun 2020
Jeffrey Pijnappels
CEO & Co-Founder
Participates in a number of projects
Gijs Meuldijk
CTO & Co-Founder
Participates in a number of projects

Advisors (0)

HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
Orion Protocol
ORION is a new kind of blockchain investment platform that combines the best features of exchanges, brokerages, and instant trading apps. The platform is built around a liquidity aggregator connected to all of the major crypto exchanges, as well as its own internal decentralized exchange, enabling users to gain the best price for their trades from a single portal. Along with powerful tools for portfolio management, ORION offers exceptional security, convenience, and flexibility. The platform is suitable for experienced traders, institutional investors, and newcomers alike.
Active
Review.Network
Review.Network is a project that aims to create a unique trusted high-intelligence user-company feedback platform based on blockchain and AI technologies. Review.Network provides direct communication between companies and customers, that helps carry on efficient top-tier market research feedback without any mediator. Our model also directly rewards participants for their valuable feedback. The platform's community can gain coins by producing content and working with quality reviews on the Review.Network platform. With the smart recommendation system implemented, it is easier for members to find the best goods and services with ease. The REW is the digital currency of the Review.Network platform. Companies purchase coins to conduct market research on the platform and reward users in exchange for the feedback they leave.
Upcoming
Little Phil
Powered by blockchain technology, the little Phil platform is an entirely new way of giving that fixes trust issues with charities using a public ledger, smart contracts and unique digital identities (UDID) to provide givers with the Proof of Need and Proof of Impact required to re-establish trust in giving to charity. Little Phil uses blockchain technology and user experience (UX) designed around a positive psychology framework to allow people to have the oversight, control and emotional connection of a philanthropist, without giving large amounts. People are able to give on their terms through their smartphone and track their giving all the way to the moment it’s received. This will create an engaging experience that makes them genuinely feel the positive impact they have had on their cause. In addition to this, charities will have solutions to their fundraising and exploitation concerns at a much lower cost than they currently incur.
Upcoming
Talentchain
TalentChain, powered by Blockchain, bridges the prevalent trust deficit among students, universities, employees, recruiters and govt bodies, and serves as a single source of truth for all the stakeholders. It enables considerable and tangible cost reduction in qualifying learning and education admissions, recruitment and related statutory processes. Talentchain is a unique presentation of the knowledge asset that is securely verifiable and endorsable across various stakeholders.
Active
BERTINITY
BERTINITY is a disruptive innovation and a fully anonymous and No KYC blockchain financial ecosystem.
Upcoming
MediLOT
MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.